4553 logo

Towa Pharmaceutical Co., Ltd. Stock Price

TSE:4553 Community·JP¥202.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

4553 Share Price Performance

JP¥4,115.00
915.00 (28.59%)
JP¥4,115.00
915.00 (28.59%)
Price JP¥4,115.00

4553 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk average dividend payer.

5 Risks
3 Rewards

Towa Pharmaceutical Co., Ltd. Key Details

JP¥273.7b

Revenue

JP¥174.6b

Cost of Revenue

JP¥99.1b

Gross Profit

JP¥93.9b

Other Expenses

JP¥5.3b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 06, 2026
106.65
36.21%
1.92%
120.4%
View Full Analysis

About 4553

Founded
1951
Employees
4923
CEO
Itsuro Yoshida
WebsiteView website
www.towayakuhin.co.jp

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. It operates through two segments; Domestic and Overseas. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from Tablets, Capsules, Injectable, Patches, eye drops, and other products. It also offers IT service related to healthcare; disease risk testing services; and quasi drugs. In addition, the company is involved in research and development and production of active pharmaceutical ingredients, intermediates, support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes. The company was founded in 1951 and is headquartered in Osaka, Japan.

Recent 4553 News & Updates

Recent updates

No updates